as on
| Source : BSE
as on August 20, 2025 at 4:01 PM IST
Day's Low
5.71%
Downside
52 Week's Low
52 Week's High
49.67%
Downside
27.30%
Upside
Market Stats | |
Previous Close | ₹39.50 |
Open | ₹41.40 |
Volume | 13.57K |
Upper Circuit | ₹41.47 |
Lower Circuit | ₹37.53 |
Day's Low | ₹39.1 |
Day's High | ₹41.47 |
52 Week Low | ₹20.87 |
52 Week High | ₹52.79 |
Returns % | |
1 Month Return | -11.65 % |
3 Month Return | + 41.37 % |
1 Year Return | + 89.27 % |
3 Year Return | + 419.74 % |
5 Year Return | + 1035.06 % |
Check Novelix Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹98.55 Cr
Return on Equity (ROE)
-0.24
PE Ratio (TTM)
-14.42
Return on capital employed (ROCE)
-0.24
Industry PE ratio
43.53
Beta (LTM)
0.4
P/B Ratio
1.89
Dividend Yield
0PEG Ratio
-10.6
Quarterly Earnings Growth YOY
-142.86
EPS (TTM)
-2.5
Sector
Pharmaceuticals
Book Value
9.14
Technical Analysis
Bullish
View Technical Analysis
Track how Novelix Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.
Novelix Pharmaceuticals Ltd in the last 5 years
Lowest (-38.24x)
January 31, 2018
Today (-14.42x)
August 19, 2025
Industry (43.53x)
August 19, 2025
Highest (-1.18x)
September 29, 2021
Today’s Price to Earnings Ratio: -14.42x
Get the annual and quarterly financial summary of Novelix Pharmaceuticals Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Novelix Pharmaceuticals Ltd.
Novelix Pharmaceuticals Ltd’s net profit fell -140.63% since last year same period to ₹0.13Cr in the Q2 2022-2023. On a quarterly growth basis, Novelix Pharmaceuticals Ltd has generated -85.71% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending June 2012, Novelix Pharmaceuticals Ltd has declared dividend of ₹0.30 per share on 23 Jul 2012 - translating a dividend yield of 1.47%.
Read More about DividendsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Novelix Pharmaceuticals Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 52.75% | ||
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 47.25% | 41.31 | |
Others | 0% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Novelix Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 98.55 | 207.01% | 0.00 | -3 | 8 | |
BUY | 8,013.96 | 10.61% | 0.72 | 3,597 | 4,565 | |
NA | 45.19 | -16.85% | 0.00 | -22 | 104 | |
NA | 714.35 | 63.1% | 0.58 | 13 | 154 | |
NA | 46.99 | 19.79% | 0.50 | 1 | 67 |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 3 months, Novelix Pharma. stock has moved up by 41.4%
Retail Holding Up
Retail Investor have increased holdings from 33.44% to 47.25% in Jun 2025 quarter
Best in 3 Years
In the last 3 years, Novelix Pharma. has outperformed top 5 stocks with highest market-cap in Drug Retailers
Best in 1 Year
In the last 1 year, Novelix Pharma. has outperformed top 5 stocks with highest market-cap in Drug Retailers
Promoter Holding Down
Promoters have decreased holdings from 66.56% to 52.75% in Jun 2025 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 1.43 Cr → 1.3 Cr (in ₹), with an average decrease of 9.1% per quarter
Profit Down
Netprofit is down for the last 2 quarters, -0.07 Cr → -0.13 Cr (in ₹), with an average decrease of 85.7% per quarter
Organisation | Novelix Pharmaceuticals Ltd |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Novelix Pharmaceuticals Ltd share price today stands at ₹41.47, Open: ₹41.4, Previous Close: ₹39.5, High: ₹41.47, Low: ₹39.1, 52 Week High: ₹52.79, 52 Week Low: ₹20.87 as on .
To buy Novelix Pharmaceuticals Ltd shares, you need to follow these steps:
Today's traded volume of Novelix Pharmaceuticals Ltd is 13.57K. Which means that 13.57K shares of Novelix Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Novelix Pharmaceuticals Ltd is ₹98.55 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Novelix Pharmaceuticals Ltd’s 52 week high is ₹52.79 and 52 week low is ₹20.87. The current share price of Novelix Pharmaceuticals Ltd is ₹41.47, which is -21.44% down from its 52 week high and 98.71% up from its 52 week low.